Yali Zhou
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- Lipid metabolism and biosynthesis 7
- Hematology 13
- Iron Metabolism and Disorders 6
Yali Zhou
109 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 456
- Nephrology 175
- Molecular Biology 1.3k
- Internal Medicine 66
- Genetics 163
Countries citing papers authored by Yali Zhou
This map shows the geographic impact of Yali Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Zhou more than expected).
Fields of papers citing papers by Yali Zhou
This network shows the impact of papers produced by Yali Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Zhou. The network helps show where Yali Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Yali Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 5 | |
| 7 | NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells Hit paper breakdown → | 2022 | 132 |
| 8 | CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2021 | 202 |
| 9 | 2021 | 12 | |
| 10 | 2020 | 20 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2019 | 0 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 51 | |
| 19 | 2018 | 14 | |
| 20 | 2016 | 0 |
About Yali Zhou
Yali Zhou is a scholar working on Biochemistry, Hematology, Cancer Research, Nephrology and Genetics, having authored 115 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Hemoglobinopathies and Related Disorders (7 papers), MicroRNA in disease regulation (7 papers), Lipid metabolism and biosynthesis (7 papers), Iron Metabolism and Disorders (6 papers), Renal Diseases and Glomerulopathies (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (456 citations), Nephrology (175 citations), Molecular Biology (1.3k citations), Internal Medicine (66 citations) and Genetics (163 citations). Yali Zhou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hui Zheng, Jun Li, Duanqing Pei, Guangjin Pan, Handong Wang, Zhaoyang Wang, Peiquan Zhao, Songxia Quan, Yihao Zhu and Weidong Chen. Their work appears in journals such as Scientific Reports, Blood, Experimental Biology and Medicine, Plant Molecular Biology Reporter and Journal of Power Sources.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.